Is IGF-1 DES safe?
No human safety data
CAnimal and cell studiesNot approvedas of 2026-10-26
Nothing is known from human use. The expected risks are those of IGF-1 itself. One is low blood sugar, since IGF-1 at high concentrations acts on insulin receptors. The other is a theoretical boost to tumour growth. A version that evades binding proteins would be expected to cause sharper low blood sugar. Nobody tests online products for identity or purity. 13
More on IGF-1 DES
Citations
- Ross 1989, Biochemical Journal: IGF binding proteins inhibit IGF-1 and IGF-2 but not des(1-3)IGF-1 doi.org
- Martin 1991, Am J Physiol: IGF-I and its variant des-(1-3)IGF-I enhance growth in rats with reduced renal mass doi.org
- Dominikowski 2026, Front Endocrinol: performance-enhancing peptides that act on the GH-IGF-1 axis, review doi.org
Reference information only, not medical advice. Drawn from the IGF-1 DES article, fact-checked against the cited sources. No dosing anywhere on this site.